Navigation Links
First Implant of DuraHeart(TM) Left Ventricular Assist System (LVAS) in Japanese Clinical Trial
Date:10/31/2008

ANN ARBOR, Mich., Oct. 31 /PRNewswire/ -- Terumo Heart Inc. announced that the first DuraHeart(TM) Left Ventricular Assist System (LVAS) was implanted in October at the University of Tokyo Hospital in Japan. Terumo Corporation will continue efforts toward an early application for approval for manufacture and sales in Japan.

Terumo's LVAS is the world's first third generation left ventricular assist system combining a centrifugal pump with a magnetically levitated impeller. The product received the CE mark in Europe in 2007 and began its U.S. Pivotal Trial in July 2008.

The "Mag-Lev" centrifugal pump technology was developed by Dr. Akamatsu, former professor of the Faculty of Engineering, Kyoto University in collaboration with NTN Corporation. The development base was moved to the U.S. in 2000 to continue product realization and commercialization.

In Japan, the Ministry of Health, Labor and Welfare highlighted implantable left ventricular assist devices in the "Council Regarding Early Introduction of Medical Equipment with Medical Needs."

Terumo Heart, Inc. is a U.S. subsidiary of Terumo Corporation with headquarters and manufacturing facilities in Ann Arbor, Michigan. The company's focus is the innovation and introduction of products to improve the quality of healthcare for heart failure patients. Terumo Corporation, located in Tokyo, Japan, is a leading developer, manufacturer and global marketer of a wide array of medical products. DuraHeart is limited to investigational use only in the United States, and is CE marked in Europe.


'/>"/>
SOURCE Terumo Heart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. The First Years True Fit C630 Convertible Car Seat Recieves Highest Given Rating From the National Highway Traffic Safety Administration
2. First evidence that prenatal exposure to famine may lead to persistent epigenetic changes
3. Obama Puts Healthcare, Economic Relief for Middle Class First in Prime-Time Special
4. WPI receives award from Homeland Security Department to advance first-responder location
5. First Results from Hospital Trials Show Pathogens Stay Close to Patients
6. NovoLogix Launches First Annual Symposium for Healthcare Thought Leaders
7. Dr. Henry Barnett becomes first person outside Europe to receive Karolinska Stroke Award
8. Evolution Physical Therapy First Clinic in Southern California to Introduce NASA-Designed Anti-Gravity Treadmill for Public Use
9. Fight begins to eradicate fatal parasite; first vaccines delivered following major funding award
10. Mylans Matrix First-to-File on Generic Version of Vfend(R) Antifungal
11. P&G Reports First Quarter EPS of $1.03 Up 12% on 9% Sales Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2017)... ... September 20, 2017 , ... “The Financial Favor of God; ... Favor of God; Second Edition” is the creation of published author, Brooks Rathell. , ... opportunity to talk to you about the financial favor of God. Not only does ...
(Date:9/20/2017)... ... ... “Monique”: is the story of Monique, whose mother’s deteriorating physical condition forces the ... has owned four beauty salons and written a book regarding the author’s success in ... , “The doctor’s office was only three blocks away, and she could walk it, ...
(Date:9/19/2017)... ... September 19, 2017 , ... Only a few physicians were selected to receive ... Ross A. Clevens, MD, FACS . The founder and medical director of Clevens ... who trained at Yale, Harvard and the University of Michigan. He has served patients ...
(Date:9/19/2017)... ... September 19, 2017 , ... PAPA Healthcare, Inc. announced ... called, “PAPA Healthcare helps fill gaps, provide essential insights, and improve productivity.” ... operations by leveraging PAPA Healthcare’s post-acute productivity and analytics solutions. , St. Vincent’s ...
(Date:9/19/2017)... ... September 19, 2017 , ... Peter Chandonait, ... President’s Malaria Initiative (PMI) Africa Indoor Residual Spraying (AIRS) Project , has ... , The Innovation to Action Award, a USAID Catalyst Award, recognizes USAID staff ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... N.J. , Sept. 5, 2017  Getinge, ... has created a vibrant charitable donation program -- ... and support congenital heart defect research by The ... providers and the general public are encouraged to ... and submit the completed artwork to the gallery ...
(Date:9/1/2017)... Michael Penna , President and CEO ... for growth in his response to the July 13, ... seeking a buyer for eMDs. Penna,s company, Complete HealthCare ... Value Added Reseller and national leader in the independent ... "As the healthcare market continues to dictate consolidation, healthcare ...
Breaking Medicine Technology: